Chronic Obstructive Pulmonary Disease (COPD): Causes, Diagnosis, GOLD Classification & Treatment

Chronic Obstructive Pulmonary Disease, or COPD, is a progressive respiratory condition that results in airflow obstruction due to damage and inflammation in the lungs. This post explores the causes, clinical features, diagnostic strategies, and up-to-date management of COPD based on the latest GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines.


๐Ÿ” What Is COPD?

COPD is a chronic obstructive pulmonary disease marked by irreversible airflow obstruction. It occurs due to a combination of:

  • Small airway obstruction
  • Parenchymal (alveolar) destruction

This obstructive pattern leads to difficulty in exhaling air out of the lungs.

COPD vs Asthma

  • Asthma = Reversible airflow obstruction
  • COPD = Irreversible airflow obstruction

๐Ÿ”ฌ Types of COPD

COPD comprises two overlapping conditions:

1. Chronic Bronchitis

Defined as a productive cough lasting for at least 3 months per year for 2 consecutive years. Caused mainly by:

  • Smoking-induced damage
  • Mucus hypersecretion
  • Bronchial obstruction

2. Emphysema

Characterized by destruction of alveoli and enlargement of airspaces distal to terminal bronchioles. This leads to poor gas exchange and breathlessness.

๐Ÿ”ธ In practice, most COPD patients have features of both conditions.


โš ๏ธ Causes of COPD

Exogenous Causes

  • Smoking (90% of cases)
  • Air pollution
  • Occupational exposure (coal, silica, fumes)
  • Indoor biomass fuel (wood, animal dung)

Endogenous Causes

  • Alpha-1 Antitrypsin Deficiency (in young non-smokers)
  • IgA deficiency
  • Kartagener syndrome

๐Ÿ“Š GOLD Classification of COPD

COPD severity is classified using:

  • Spirometry: Measures FEVโ‚ (Forced Expiratory Volume in 1 second)
  • CAT Score: COPD Assessment Test (symptom-based)
  • mMRC Dyspnea Scale: Based on breathlessness during activities
  • Exacerbation Frequency: Number of flare-ups per year

Spirometry-Based GOLD Grades

GOLD GradeSeverityFEVโ‚ % Predicted
GOLD 1Mildโ‰ฅ 80%
GOLD 2Moderate50โ€“79%
GOLD 3Severe30โ€“49%
GOLD 4Very Severe< 30%

๐Ÿงช Clinical Features of COPD

  • Chronic productive cough (especially in chronic bronchitis)
  • Dyspnea (initially exertional, then at rest)
  • Pursed-lip breathing
  • Tripod position (leaning forward with hands on knees)
  • Prolonged expiration
  • Barrel-shaped chest
  • Wheezing and decreased breath sounds

๐Ÿ”Ž Diagnostic Workup

1. Spirometry

  • Diagnostic gold standard
  • FEVโ‚/FVC ratio < 70%
  • FEVโ‚ predicts severity

2. DLCO (Diffusion Test)

  • Normal in chronic bronchitis
  • โ†“ in emphysema due to alveolar destruction

3. Chest X-ray

  • Hyperinflated lungs
  • Flattened diaphragm
  • Tubular heart
  • Increased AP diameter (barrel chest)

4. ABGs (Arterial Blood Gases)

  • Indicated in severe cases or exacerbations
  • Reveals hypoxia and/or hypercapnia

5. Alpha-1 Antitrypsin Testing

  • Especially in young, non-smoker patients

6. CBC

  • Elevated hematocrit due to chronic hypoxia

๐Ÿ’Š Treatment of Stable COPD

๐Ÿ”ธ Short-Acting Bronchodilators (SABAs)

  • Albuterol (90 mcg per puff): Used 4โ€“6 hourly PRN

๐Ÿ”ธ Long-Acting Bronchodilators (LABAs)

  • Salmeterol (50 mcg BID)
  • Preferred in moderate to severe COPD

๐Ÿ”ธ Long-Acting Muscarinic Antagonists (LAMAs)

  • Tiotropium (18 mcg OD)
  • Improve symptoms and reduce exacerbations

๐Ÿ”ธ Inhaled Corticosteroids (ICS)

  • Used in combination with LABA or LAMA for frequent exacerbators (Group C or D)

๐Ÿ”ธ Antibiotic Prophylaxis

  • Azithromycin may reduce exacerbation risk

๐ŸŒฌ๏ธ Long-Term Oxygen Therapy (LTOT)

  • Indicated when Oโ‚‚ saturation โ‰ค 88%
  • Target Oโ‚‚ saturation: 90โ€“93%
  • Improves survival in hypoxemic patients

โš ๏ธ Never give 100% oxygen โ€” risk of respiratory depression due to COโ‚‚ retention.


๐Ÿงช Additional Therapies

  • Mucolytics: N-acetylcysteine to loosen mucus
  • Theophylline: Reserved for refractory cases
  • Surgery: Lung volume reduction, bullectomy, or lung transplant in advanced disease

๐Ÿ’ก Preventive Measures

  • Smoking cessation: Most effective intervention to slow progression
  • Vaccinations:
    • Annual influenza vaccine
    • Pneumococcal vaccine (for all COPD patients, especially age >65)
  • Chest physiotherapy: Postural drainage for mucus clearance
  • Pulmonary rehab: Exercise training, education, nutritional advice

โš ๏ธ Complications of COPD

  • Chronic respiratory failure
  • Cor pulmonale (right heart failure)
  • Recurrent infections
  • Spontaneous pneumothorax
  • Polycythemia due to chronic hypoxia

๐Ÿงพ Summary

  • COPD is an irreversible obstructive airway disease caused by chronic exposure to toxins (mainly smoking).
  • Diagnosis is confirmed with spirometry (FEVโ‚/FVC < 70%).
  • GOLD classification helps guide treatment based on spirometry, symptoms, and exacerbation history.
  • Management includes bronchodilators, ICS, LTOT, smoking cessation, vaccinations, and rehab.
  • Only smoking cessation and long-term oxygen therapy have shown to reduce mortality.

Leave a Comment

Your email address will not be published. Required fields are marked *